Distribution of 2-aminofluorene and p-aminobenzoic acid N- acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
Mouse tissues were tested to determine which contain measurable N- acetyltransferase (NAT) activity and to compare levels of activity between rapid and slow acetylator mice. The experiments used inbred C57BL/6J (B6)-mice and slow acetylator congenic B6.A-Nat(s)-mice. Tissue cytosols were incubated with either 2-aminofluorene (153786) or p-aminobenzoic-acid (150130). The tissues studied included samples taken from the gastrointestinal tract, lymphoid tissue, skin, blood components, and other major organs. With the exception of blood plasma and seminal vesicles, NAT activity was demonstrated in all tissues examined. The highest activity was observed in Peyer's patches with either substrate, and lymphoid tissue, in general, being high in NAT activity as was the skin and samples from the digestive system. In most tissues the acetylator polymorphism was apparent for both p-aminobenzoic-acid and 2-aminofluorene. With p-aminobenzoic-acid the difference between rapid and slow acetylator phenotypes was usually greater than with 2-aminofluorene. Immunoblots using an antiNAT antibody raised in rabbits demonstrated the presence of NAT in the 33 tissues of rapid and slow acetylator mice as well as the absence of NAT in plasma and seminal vesicles. The authors conclude that there is a widespread distribution of NAT activity and that a relative abundance of extrahepatic N-acetylation capacity exists in the mouse.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.